Jane Street Group, LLC Ocugen, Inc. Put Options Transaction History

Jane Street Group, LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 May 17, 2022	BUY	$2.34 - $4.72 $39,312 - $79,296	16,800 Added 5.37%	329,400 $1.09 Million
Q4 2021 Feb 15, 2022	BUY	$4.38 - $15.67 $258,420 - $924,530	59,000 Added 23.26%	312,600 $1.42 Million
Q3 2021 Nov 16, 2021	SELL	$6.36 - $8.51 $6.71 Million - $8.97 Million	-1,054,500 Reduced 80.61%	253,600 $1.82 Million
Q2 2021 Aug 16, 2021	BUY	$5.52 - $15.68 $4.94 Million - $14 Million	894,100 Added 215.97%	1,308,100 $10.5 Million
Q1 2021 May 18, 2021	BUY	$1.66 - $15.81 $687,240 - $6.55 Million	414,000 New	414,000 $2.81 Million

123

78.3M

535K

523K

Ticker OCGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,566,000
Market Cap $169M
Description
Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.